Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin effects on triglycerides in T2D
NCT01527747Phase 4Suspended
- Sponsor
- Oregon Health & Science University
- Start
- Jan 2012
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in type 2 diabetes mellitus (T2DM), hypertriglyceridemia, sponsored by Oregon Health & Science University. Started Jan 2012; status: suspended.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)hypertriglyceridemia
Beyond the preview
Go deeper on NCT01527747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01527747.